Crucial Role of NO and Endothelium-Derived Hyperpolarizing Factor in Human Sustained Conduit Artery Flow-Mediated Dilatation
- 1 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 48 (6), 1088-1094
- https://doi.org/10.1161/01.hyp.0000246672.72188.bd
Abstract
Whether NO is involved or not in sustained conduit artery flow-mediated dilatation in humans remains unclear. Moreover, the role of endothelium-derived hyperpolarizing factor (EDHF), synthesized by cytochrome epoxygenases and acting through calcium-activated potassium channels, and its relationship with NO during flow-mediated dilatation have never been investigated previously. In 12 healthy subjects we measured radial artery diameter (echotracking) and blood flow (Doppler) during flow-mediated dilatation induced by gradual distal hand skin heating (34 to 44°C), during the local infusion of saline and inhibitors of NO synthase ( N G -monomethyl- l -arginine [ l -NMMA]: 8 to 20 μmol/min per liter), calcium-activated potassium channels (tetraethylammonium chloride: 9 μmol/min per liter), and cytochrome epoxygenases (fluconazole: 0.4 to 1.6 μmol/min per liter), alone and in combination. Mean wall shear stress, the flow-mediated dilatation stimulus, was calculated at each level of flow, and the diameter–wall shear stress relationship was constructed. During heating, compared with saline, the diameter–shear stress relationship was shifted downward by l -NMMA, tetraethylammonium, fluconazole, and, in a more pronounced manner, by the combinations of l -NMMA with tetraethylammonium or with fluconazole. Therefore, maximal radial artery flow-mediated dilatation, compared with saline (0.62±0.03 mm), was decreased under our experimental conditions by l -NMMA (−39±4%), tetraethylammonium chloride (−14±4%), fluconazole (−18±6%), and to a greater extent, by the combinations of l -NMMA with tetraethylammonium (−64±4%) or with fluconazole (−71±3%). This study demonstrates that NO and a cytochrome-related EDHF are involved in peripheral conduit artery flow-mediated dilatation in humans during sustained flow conditions. Moreover, the synergistic effects of the inhibitors strongly suggest a functional interaction between NO and EDHF pathways.Keywords
This publication has 32 references indexed in Scilit:
- Evidence for a basal release of a cytochrome-related endothelium-derived hyperpolarizing factor in the radial artery in humansAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Epoxyeicosatrienoic Acids Are Released to Mediate Shear Stress–Dependent Hyperpolarization of Arteriolar Smooth MuscleCirculation Research, 2005
- Inhibition of Cytochrome P450 2C9 Improves Endothelium-Dependent, Nitric Oxide–Mediated Vasodilatation in Patients With Coronary Artery DiseaseCirculation, 2004
- Role of Endothelium-Derived Hyperpolarizing Factor in Human Forearm CirculationHypertension, 2003
- Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazoleClinical Science, 2003
- Effects of the Antifungal Agents on Oxidative Drug MetabolismClinical Pharmacokinetics, 2000
- Flow-induced vasodilation of the human brachial artery is impaired in patients < 40 years of age with coronary artery diseaseThe American Journal of Cardiology, 1996
- Crucial role of endothelium in the vasodilator response to increased flow in vivo.Hypertension, 1986
- Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in manNature, 1985
- STUDIES ON VASOMOTOR TONE. I. THE EFFECT OF THE TETRA-ETHYLAMMONIUM ION ON THE PERIPHERAL BLOOD FLOW OF NORMAL SUBJECTS 12Journal of Clinical Investigation, 1949